Recruiting
Phase 1

TGFBR-2 KO CD70 CAR NK Cell Therapy

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT07072234

Conditions

Clear Cell Carcinoma

Phase 1

Growth Factor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lymphodepleting chemotherapy

Dexamethasone

Fludarabine

Cyclophosphamate

TGFBR-2 KO CD70 CAR NK

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-10-07.